2 x University of Hull-funded PhDs: Diabetes and its Comorbidities: A Multidisciplinary Approach cluster
Committed to improving the health of the region and beyond, the University of Hull is investing in PhD scholarships for 2023 entry to investigate some of this century’s most urgent challenges. We are pleased to offer the following PhDs as part of the 'Diabetes and its Comorbidities: A Multidisciplinary Approach' cluster at Hull York Medical School. Designed to attract the best talent and deliver great research that has impact, these scholarships are open to high-calibre students.
The positions are based at the University of Hull. If you have any questions, we welcome you to contact the primary supervisor for an informal discussion.
Please see the project advertisements for details of the PhDs on the University of Hull website:
Vascular endothelial cell damage, its role in vascular complications of diabetes and the potential of dietary interventions scholarship - closing date for applications is 16 May 2023
Development and characterisation of novel antioxidant H2S-releasing compounds to prevent diabetic kidney disease scholarship - closing date for applications is 31 May 2023
Cardioimmunology: Dissecting immune mechanisms underlying infection-driven heart disease
The goal of this PhD programme is to better understand the immune mechanisms that contribute to heart tissue damage in response to infection.
The position is based at the University of York. If you have any questions, we welcome you to contact the primary supervisor for an informal discussion.
Visit FindPhD.com for full details and to apply: Cardioimmunology: Dissecting immune mechanisms underlying infection-driven heart disease
The closing date for applications is 26 May 2023.
MSc (by Thesis): A Targeted Approach To Reduce Risk of Blood Clotting in Myeloproliferative Neoplasm Patients
This MSc (by Thesis) is an exciting opportunity to test whether existing medication for the management of type 2 diabetes can effectively and safely reduce thrombosis in certain blood cancers, therefore improving quality of life for people with cancer.
The position is based at the University of Hull. If you have any questions, we welcome you to contact the primary supervisor for an informal discussion.
Visit FindaMasters.com for full details and to apply: A Targeted Approach To Reduce Risk of Blood Clotting in Myeloproliferative Neoplasm Patients
The closing date for applications is 1 June 2023.